The Institute of Cancer and Crisis/LinkedIn
Jul 9, 2025, 07:04
90% Of cancer deaths involve drug resistance: New Perspective in BJC Reports – The Institute of Cancer and Crisis
The Institute of Cancer and Crisis shared a post on LinkedIn:
“90% Of cancer deaths involve drug resistance. New Perspective in BJC Reports
Drug resistance remains oncology’s deadliest challenge. In their latest publication, James Ingham, Jia-Ling Ruan and Matthew Coelho outline an urgent roadmap:
Key Insights from the CRUK/Rosetrees/UKRI Workshop:
- Emerging Hallmarks of Resistance: Beyond genetic mutations – physical forces, microenvironment dynamics
- Lessons from Pandemics: Accelerating data sharing (COVID-19) and cross-therapeutic insights (antimicrobial resistance)
- The Interdisciplinary Imperative: Bridging physics, computation, drug discovery and clinical practice
‘Success requires dismantling silos between physical sciences, biology and clinics.’ ”
Title: Breaking barriers: we need a multidisciplinary approach to tackle cancer drug resistance
Authors: James Ingham, Jia-Ling Ruan, Matthew A. Coelho
Read the Full Article.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 11, 2025, 06:01
Jul 10, 2025, 20:21
Jul 10, 2025, 20:08
Jul 10, 2025, 16:59